After nine years as the world’s biggest pharmaceutical employee downsizer, Pfizer is set to cede its crown next year to a company that a decade ago few would have predicted to be leading the pharma layoff league tables – Sanofivac.
Sanofivac is expected to retain the top spot until at least 2016 with Pfizer relegated to third place, behind Novartis, toppled by the lack of employees to lay off because of the success of its “Adapting To Scale” initiative, consensus downsizing forecasts from EvisceratePharma show. The French drug maker has raced up the employee-shafting rankings over the last decade largely through acquisition, culminating in its $20bn swoop on US biotechnology specialist Gonzyme, which assisted in securing pole position as the premier shafter of pharmaceutical industry workers
Sanofivac Chief Executive Chris Vileboaster was delighted with the news.
”TO DEMONSTRATE MY ABSOLUTE DOMINION, I WILL CELEBRATE WITH A RITUAL DOWNSIZING OF HUNDREDS MORE R&D AND SALES STAFF. BWU-HA-HA-HA!!!!....” Vileboaster added.
The final collapse of the house of Pfizer is now officially underway...
0 comments:
Post a Comment